Ruzicka T - Search Results

1

Fluorescence diagnostics as a guide for demarcation and biopsy of suspected anal cancer.

Kriz M, Hegyi J, Ruzicka T, Berking C. Kriz M, et al. Among authors: ruzicka t. Int J Dermatol. 2012 Jan;51(1):31-4. doi: 10.1111/j.1365-4632.2011.04951.x. Int J Dermatol. 2012. PMID: 22182375

2

New developments in fluorescence diagnostics.

Hegyi J, Hegyi V, Ruzicka T, Arenberger P, Berking C. Hegyi J, et al. Among authors: ruzicka t. J Dtsch Dermatol Ges. 2011 May;9(5):368-72. doi: 10.1111/j.1610-0387.2011.07582.x. Epub 2011 Jan 21. J Dtsch Dermatol Ges. 2011. PMID: 21251227 Review. English, German.

3

Sentinel lymph node in Merkel cell carcinoma: to biopsy or not to biopsy?

Sattler E, Geimer T, Sick I, Flaig MJ, Ruzicka T, Berking C, Kunte C. Sattler E, et al. Among authors: ruzicka t. J Dermatol. 2013 May;40(5):374-9. doi: 10.1111/1346-8138.12072. Epub 2013 Feb 18. J Dermatol. 2013. PMID: 23414107

4

The outcome of patients with melanoma is not associated with the time point of lymphatic mapping with respect to excisional biopsy of the primary tumor.

Gauwerky KJ, Kunte C, Geimer T, Baumert J, Flaig MJ, Ruzicka T, Schmid-Wendtner MH, Berking C. Gauwerky KJ, et al. Among authors: ruzicka t. Dermatology. 2010;220(4):355-62. doi: 10.1159/000300047. Epub 2010 May 12. Dermatology. 2010. PMID: 20460880 Free article.

5

Analysis of predictive factors for the outcome of complete lymph node dissection in melanoma patients with metastatic sentinel lymph nodes.

Kunte C, Geimer T, Baumert J, Konz B, Volkenandt M, Flaig M, Ruzicka T, Berking C, Schmid-Wendtner MH. Kunte C, et al. Among authors: ruzicka t. J Am Acad Dermatol. 2011 Apr;64(4):655-62; quiz 637. doi: 10.1016/j.jaad.2010.02.047. J Am Acad Dermatol. 2011. PMID: 21315477

6

A controlled trial of photodynamic therapy of actinic keratosis comparing different red light sources.

Giehl KA, Kriz M, Grahovac M, Ruzicka T, Berking C. Giehl KA, et al. Among authors: ruzicka t. Eur J Dermatol. 2014 May-Jun;24(3):335-41. doi: 10.1684/ejd.2014.2364. Eur J Dermatol. 2014. PMID: 24876164 Clinical Trial.

7

Noninvasive monitoring of basal cell carcinomas treated with systemic hedgehog inhibitors: pseudocysts as a sign of tumor regression.

Maier T, Kulichova D, Ruzicka T, Berking C. Maier T, et al. Among authors: ruzicka t. J Am Acad Dermatol. 2014 Oct;71(4):725-30. doi: 10.1016/j.jaad.2014.04.007. Epub 2014 Jun 11. J Am Acad Dermatol. 2014. PMID: 24928708

8

Lupus erythematosus-like skin eruption after vemurafenib therapy.

Reinholz M, Berking C, Hermans C, Ruzicka T, Braun-Falco M. Reinholz M, et al. Among authors: ruzicka t. J Am Acad Dermatol. 2014 Oct;71(4):e159-60. doi: 10.1016/j.jaad.2014.07.006. J Am Acad Dermatol. 2014. PMID: 25219748 Free article. No abstract available.

9

Low baseline levels of NK cells may predict a positive response to ipilimumab in melanoma therapy.

Tietze JK, Angelova D, Heppt MV, Ruzicka T, Berking C. Tietze JK, et al. Among authors: ruzicka t. Exp Dermatol. 2017 Jul;26(7):622-629. doi: 10.1111/exd.13263. Epub 2017 Feb 19. Exp Dermatol. 2017. PMID: 27892653

10

Photodynamic therapy for granuloma annulare: more than a shot in the dark.

Weisenseel P, Kuznetsov AV, Molin S, Ruzicka T, Berking C, Prinz JC. Weisenseel P, et al. Among authors: ruzicka t. Dermatology. 2008;217(4):329-32. doi: 10.1159/000155643. Epub 2008 Sep 18. Dermatology. 2008. PMID: 18799877

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

866 results

Search Page

Filters